174 related articles for article (PubMed ID: 23510472)
21. Mere15, a novel polypeptide from Meretrix meretrix, inhibits adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMPs.
Wang H; Wei J; Wu N; Liu M; Wang C; Zhang Y; Wang F; Liu H; Lin X
Pharm Biol; 2013 Feb; 51(2):145-51. PubMed ID: 23134156
[TBL] [Abstract][Full Text] [Related]
22. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
23. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-κB system.
Yang B; Zhang D; Qian J; Cheng Y
Mol Cell Biochem; 2020 Nov; 474(1-2):199-208. PubMed ID: 32737771
[TBL] [Abstract][Full Text] [Related]
24. IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells.
Cheng CY; Kuo CT; Lin CC; Hsieh HL; Yang CM
Br J Pharmacol; 2010 Aug; 160(7):1595-610. PubMed ID: 20649564
[TBL] [Abstract][Full Text] [Related]
25. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636
[TBL] [Abstract][Full Text] [Related]
26. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.
Kim SE; Thanh Thuy TT; Lee JH; Ro JY; Bae YA; Kong Y; Ahn JY; Lee DS; Oh YM; Lee SD; Lee YS
Exp Mol Med; 2009 Apr; 41(4):277-87. PubMed ID: 19299917
[TBL] [Abstract][Full Text] [Related]
28. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
29. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
[TBL] [Abstract][Full Text] [Related]
30. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
31. Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Wen YL; Li L
Genet Mol Res; 2015 Dec; 14(4):19342-8. PubMed ID: 26782587
[TBL] [Abstract][Full Text] [Related]
32. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102
[TBL] [Abstract][Full Text] [Related]
33. Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression.
Zhou W; Chen X; Hu Q; Chen X; Chen Y; Huang L
BMC Cancer; 2018 May; 18(1):580. PubMed ID: 29788922
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
Shishodia S; Aggarwal BB
Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
[TBL] [Abstract][Full Text] [Related]
35. PKCζ, MMP‑2 and MMP‑9 expression in lung adenocarcinoma and association with a metastatic phenotype.
Cai X; Zhu H; Li Y
Mol Med Rep; 2017 Dec; 16(6):8301-8306. PubMed ID: 28983601
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Li X; Tai HH
Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
[TBL] [Abstract][Full Text] [Related]
37. Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases.
Wang G; Tian W; Liu Y; Ju Y; Shen Y; Zhao S; Zhang B; Li Y
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):548-554. PubMed ID: 27224551
[TBL] [Abstract][Full Text] [Related]
38. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism depressing PMA-induced invasive behaviors in human lung adenocarcinoma cells by cis- and trans-cinnamic acid.
Tsai CM; Sun FM; Chen YL; Hsu CL; Yen GC; Weng CJ
Eur J Pharm Sci; 2013 Feb; 48(3):494-501. PubMed ID: 23228413
[TBL] [Abstract][Full Text] [Related]
40. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
